ISSN: 1465-3249

Journal Home

Journal Guideline

Cytotherapy Q1 Unclaimed

Elsevier B.V. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cytotherapy is a journal indexed in SJR in Cell Biology and Immunology with an H index of 105. It has a price of 2970 €. It has an SJR impact factor of 1,084 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,084.

Cytotherapy focuses its scope in these topics and keywords: cell, human, cells, therapy, stromal, mesenchymal, stem, equine, engraftment, efficacy, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Transplantation (Q1) Cancer Research (Q2) Cell Biology (Q2) Genetics (clinical) (Q2) Immunology (Q2) Immunology and Allergy (Q2) Immunology and Allergy (Q2) Oncology (Q2)

Price

2970 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,084

SJR Impact factor

105

H Index

155

Total Docs (Last Year)

345

Total Docs (3 years)

7941

Total Refs

1252

Total Cites (3 years)

327

Citable Docs (3 years)

3.6

Cites/Doc (2 years)

51.23

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cell Research Q1
Molecular Cell Q1
Nature Cell Biology Q1
Nature Microbiology Q1
Annual Review of Plant Biology Q1

Compare this journals

Aims and Scope

Best articles by citations

Mesenchymal stem-cell therapy in a regulated environment

Cell density-dependent proliferation in frequently-fed peripheral blood mononuclear cell cultures

Flow cytometric analysis of intracellular cytokines: a powerful new tool for the clinical assessment of immune responsiveness

Recent advances in hematopoietic stem cell transplantation

Selection and expansion of T cells from untreated patients with CLL: source of cells for immune reconstitution?

Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients

Minimal residual cancer

FDA-NCI Workshop on Tumor Vaccines

FDA's new regulatory paradigms for in vitro diagnostic devices

Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study

Flow cytometry in the evaluation of immune status in cancer and HIV infection

Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancer

SHOW MORE ARTICLES

Accurate calculation of blood volume to be processed by apheresis to achieve target CD34+ cell numbers for PBPC transplantation

Process validation

Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential

Transplanted BM and BM side population cells contribute progeny to the lung and liver in irradiated mice

DC-based immunotherapy of B-cell malignancies

Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation

A great adventure in cell therapy

Evaluation in vitro of the therapeutic effect of mesenchymal stem cell-conditioned medium on drug induced liver injury

Minimal tumor contamination of hematopoietic harvests from breast cancer patients can be easily detected by liquid culture assay

Clinical-scale production of granulocyte progenitor and post-progenitor cells using daniplestim, leridistim, Progenipoietin, Promegapoietin and autologous plasma

Adoptive T-cell therapy for CMV

Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection